| Bioactivity | ZLWT-37 is a potent, orally active CDKs inhibitor with IC50 values of 0.002 μM and 0.054 μM against CDK9 and CDK2, respectively. ZLWT-37 induces apoptosis and arrests the cell cycle in the G2/M phase in HCT116 cells[1]. |
| Invitro | ZLWT-37 shows antiproliferative activity with a GI50 of 0.029 μM for HCT116[1]. |
| Name | ZLWT-37 |
| Formula | C26H30ClN5O |
| Molar Mass | 464.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |